These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 25187432

  • 41. The relative selectivity of anticholinergic drugs for the M1 and M2 muscarinic receptor subtypes.
    Burke RE.
    Mov Disord; 1986; 1(2):135-44. PubMed ID: 2904117
    [Abstract] [Full Text] [Related]

  • 42. [The acute effects of dimethoate on the muscarinic-receptors of rat brains and the relationship between muscarinic-receptors and cholinesterase].
    Sun Y, Zhou Z, Hu Y, Chen J, Jin T.
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2002 Aug; 20(4):293-5. PubMed ID: 14694657
    [Abstract] [Full Text] [Related]

  • 43. Protein kinase A mediates scopolamine-induced mTOR activation and an antidepressant response.
    Dong J, Zhou Q, Wei Z, Yan S, Sun F, Cai X.
    J Affect Disord; 2018 Feb; 227():633-642. PubMed ID: 29174736
    [Abstract] [Full Text] [Related]

  • 44. Differential effects of m1 and m2 receptor antagonists in perirhinal cortex on visual recognition memory in monkeys.
    Wu W, Saunders RC, Mishkin M, Turchi J.
    Neurobiol Learn Mem; 2012 Jul; 98(1):41-6. PubMed ID: 22561485
    [Abstract] [Full Text] [Related]

  • 45. Memantine improves memory impairment and depressive-like behavior induced by amphetamine withdrawal in rats.
    Marszalek-Grabska M, Gibula-Bruzda E, Jenda M, Gawel K, Kotlinska JH.
    Brain Res; 2016 Jul 01; 1642():389-396. PubMed ID: 27085203
    [Abstract] [Full Text] [Related]

  • 46. Role of muscarinic receptors, G-proteins, and intracellular messengers in muscarinic modulation of NMDA receptor-mediated synaptic transmission.
    Aramakis VB, Bandrowski AE, Ashe JH.
    Synapse; 1999 Jun 15; 32(4):262-75. PubMed ID: 10332802
    [Abstract] [Full Text] [Related]

  • 47. Selective labeling and localization of the M4 (m4) muscarinic receptor subtype.
    Ferrari-Dileo G, Waelbroeck M, Mash DC, Flynn DD.
    Mol Pharmacol; 1994 Dec 15; 46(6):1028-35. PubMed ID: 7808421
    [Abstract] [Full Text] [Related]

  • 48. The potential antidepressant action and adverse effects profile of scopolamine co-administered with the mGlu7 receptor allosteric agonist AMN082 in mice.
    Podkowa K, Pilc A, Podkowa A, Sałat K, Marciniak M, Pałucha-Poniewiera A.
    Neuropharmacology; 2018 Oct 15; 141():214-222. PubMed ID: 30145321
    [Abstract] [Full Text] [Related]

  • 49. Identification of M(1) muscarinic receptor subtype in rat stomach using a tissue segment binding method, and the effects of immobilization stress on the muscarinic receptors.
    Anisuzzaman AS, Morishima S, Suzuki F, Tanaka T, Muramatsu I.
    Eur J Pharmacol; 2008 Dec 03; 599(1-3):146-51. PubMed ID: 18938154
    [Abstract] [Full Text] [Related]

  • 50. Subchronic administration of scopolamine reverses UCMS-induced behavior in mice via eEF2 protein dephosphorylation.
    Babii Y, Pałucha-Poniewiera A, Rafało-Ulińska A, Brański P, Pilc A.
    Pharmacol Rep; 2024 Oct 03; 76(5):1001-1011. PubMed ID: 39042346
    [Abstract] [Full Text] [Related]

  • 51. Quantitative structure-selectivity relationship for M2 selectivity between M1 and M2 of piperidinyl piperidine derivatives as muscarinic antagonists.
    Niu YY, Yang LM, Deng KM, Yao JH, Zhu L, Chen CY, Zhang M, Zhou JE, Shen TX, Chen HZ, Lu Y.
    Bioorg Med Chem Lett; 2007 Apr 15; 17(8):2260-6. PubMed ID: 17289384
    [Abstract] [Full Text] [Related]

  • 52. S32212, a novel serotonin type 2C receptor inverse agonist/α2-adrenoceptor antagonist and potential antidepressant: II. A behavioral, neurochemical, and electrophysiological characterization.
    Dekeyne A, Brocco M, Loiseau F, Gobert A, Rivet JM, Di Cara B, Cremers TI, Flik G, Fone KC, Watson DJ, Papp M, Sharp T, Serres F, Cespuglio R, Olivier B, Chan JS, Lavielle G, Millan MJ.
    J Pharmacol Exp Ther; 2012 Mar 15; 340(3):765-80. PubMed ID: 22178753
    [Abstract] [Full Text] [Related]

  • 53. Roles of the M1 muscarinic acetylcholine receptor subtype in the regulation of basal ganglia function and implications for the treatment of Parkinson's disease.
    Xiang Z, Thompson AD, Jones CK, Lindsley CW, Conn PJ.
    J Pharmacol Exp Ther; 2012 Mar 15; 340(3):595-603. PubMed ID: 22135383
    [Abstract] [Full Text] [Related]

  • 54. The role of muscarinic cholinergic receptors in the discriminative stimulus properties of clozapine in rats.
    Kelley BM, Porter JH.
    Pharmacol Biochem Behav; 1997 Aug 15; 57(4):707-19. PubMed ID: 9258998
    [Abstract] [Full Text] [Related]

  • 55. The involvement of monoaminergic neurotransmission in the antidepressant-like action of scopolamine in the tail suspension test.
    Pałucha-Poniewiera A, Podkowa K, Lenda T, Pilc A.
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Oct 03; 79(Pt B):155-161. PubMed ID: 28647535
    [Abstract] [Full Text] [Related]

  • 56. Antidepressant-like effects of kappa-opioid receptor antagonists in the forced swim test in rats.
    Mague SD, Pliakas AM, Todtenkopf MS, Tomasiewicz HC, Zhang Y, Stevens WC, Jones RM, Portoghese PS, Carlezon WA.
    J Pharmacol Exp Ther; 2003 Apr 03; 305(1):323-30. PubMed ID: 12649385
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Evidence that the M1 muscarinic receptor subtype mediates the effects of oxotremorine on masculine sexual behavior.
    Retana-Marquez S, Velazquez-Moctezuma J.
    Neuropsychopharmacology; 1993 Dec 03; 9(4):267-70. PubMed ID: 8305126
    [Abstract] [Full Text] [Related]

  • 59. Altered emotional behaviors and the expression of 5-HT1A and M1 muscarinic receptors in micro-opioid receptor knockout mice.
    Yoo JH, Lee SY, Loh HH, Ho IK, Jang CG.
    Synapse; 2004 Nov 03; 54(2):72-82. PubMed ID: 15352132
    [Abstract] [Full Text] [Related]

  • 60. Vesicular glutamate transporter 1 (VGLUT1)-mediated glutamate release and membrane GluA1 activation is involved in the rapid antidepressant-like effects of scopolamine in mice.
    Yu H, Li M, Zhou D, Lv D, Liao Q, Lou Z, Shen M, Wang Z, Li M, Xiao X, Zhang Y, Wang C.
    Neuropharmacology; 2018 Mar 15; 131():209-222. PubMed ID: 29274366
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.